Table 2.
Type of pulmonary hypertension | Causes |
---|---|
Grade 1 | |
Pulmonary arterial hypertension | Idiopathic |
Heritable: (eg BMPR, ALK1, mutations) | |
Drugs and toxins | |
Connective tissue diseases | |
HIV infection | |
Portal hypertension | |
Congenital heart disease | |
Schistosomiasis | |
Persistent pulmonary hypertension of the newborn | |
Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis | |
Grade 2 | |
Pulmonary hypertension resulting from left heart disease | LV systolic dysfunction |
LV diastolic dysfunction | |
Valvular heart disease | |
Grade 3 | |
Pulmonary hypertension resulting from lung diseases and/or hypoxia | Chronic obstructive pulmonary disease |
Interstitial lung disease | |
Other pulmonary diseases with mixed restrictive and obstructive patterns | |
Sleep-disordered breathing | |
Alveolar hypoventilation disorders | |
Chronic exposure to high altitude | |
Developmental abnormalities | |
Grade 4 | |
Chronic thromboembolic pulmonary hypertension | |
Grade 5 | |
Pulmonary hypertension with unclear and/or multifactorial mechanisms | Haematological disorders (eg myeloproliferative disorders, splenectomy) |
Systemic disorders (eg sarcoidosis, pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, neurofibromatosis, vasculitis) | |
Metabolic disorders (eg glycogen storage disease, Gaucher's disease, thyroid disorders) | |
Others: tumoural obstruction, fibrosing mediastinitis, chronic renal failure |
ALK = anaplastic lymphoma kinase; BMPR = bone morphogenetic protein receptor; LV = left ventricular